新型分段食管支架在治疗食管恶性梗阻中的临床应用  

Clinical Application of New Esophageal Stent for Malignant Esophageal Obstruction

作　　者：张丽云[1] 贡桔[1] 夏宁[1] 王忠敏[2] 

机构地区：[1]上海交通大学医学院附属瑞金医院卢湾分院放射介入科,上海200020 [2]上海交通大学医学院附属瑞金医院放射介入科,上海200025

出　　处：《中国医疗器械信息》2016年第11期13-16,共4页China Medical Device Information

摘　　要：目的:评估新型分段食管支架置入治疗食管恶性梗阻的临床疗效。方法:24例食管恶性梗阻患者,行新型分段食管支架置入,记录支架放置成功率、术后吞咽困难分级及生活质量改善(Kamofsky评分)、并发症情况。结果:24例患者均成功置入支架,术中、术后无支架相关的严重并发症。支架置入后患者吞咽困难明显改善,其中显效18例,好转5例,无改善l例。吞咽困难缓解率为95.8%(23/24)。术后2周患者吞咽困难分级较术前明显好转(t=15.91,P<0.0001),Kamofsky评分也有所改善。随访期间未发生支架移位。结论:新型分段食管支架置入治疗食管恶性狭窄安全、有效、不易移位。Objective： The aim of this study was to investigate the clinical efficacy of new stent for malignant esophageal obstruction. Method： We analysed the clinical data of 24 cases with malignant esophageal obstruction who were implanted with new stant. The postoperative efficacy observations including the success rate of stent implantation, swallow condition and complications after surgery. Results： All 24 patients were treated successfully with new stents, no complications related with stems occurred after surgery.Swanowing conditions were improved after surgery, there were 18 patients with obvious improvement, 5 patients with better improvement, 1 patient had no improvement.Remission rate of swallowing conditions was 95,8%（23/24）.Two weeks after surgery, Stooler of swallowing conditions obviously improved（t=15.91, P〈0.0001）, Kamofsky scores also improved. There were no stents migration during follow up. Conclusion： The application of new stents for malignant esophageal obstruction is safe ,effective and not easily migrate.

关 键 词：食管 恶性梗阻 支架 

分 类 号：R318[医药卫生—生物医学工程]